News & Updates

Maternal transplacental transfer of nipocalimab negligible in foetuses, neonates

In the phase II UNITY study, foetuses and neonates whose mums were receiving nipocalimab for early-onset (≤24 weeks gestational age [GA]) severe haemolytic disease of the foetus and newborn (EOS-HDFN) had minimal exposure to the drug.

ACOG article 2.4

Treatment with fezolinetant significantly reduced the frequency and severity of vasomotor symptoms (VMS), particularly hot flashes, in women during their menopausal phase, according to the SKYLIGHT 1* trial presented at ACOG 2022.

Original New Drug Application Approvals by US FDA (1-15 March 2024)

ACOG article 2.6

Treatment with fezolinetant significantly reduced the frequency and severity of vasomotor symptoms (VMS), particularly hot flashes, in women during their menopausal phase, according to the SKYLIGHT 1* trial presented at ACOG 2022.

ACOG article 2.1

Treatment with fezolinetant significantly reduced the frequency and severity of vasomotor symptoms (VMS), particularly hot flashes, in women during their menopausal phase, according to the SKYLIGHT 1* trial presented at ACOG 2022.

ACOG article 2.7

Treatment with fezolinetant significantly reduced the frequency and severity of vasomotor symptoms (VMS), particularly hot flashes, in women during their menopausal phase, according to the SKYLIGHT 1* trial presented at ACOG 2022.

Which factors predict substance use initiation in kids?

Sociodemographic factors appear to be the strongest predictors of substance use initiation during early adolescence, according to a study. The addition of resource-intensive measures, such as hormones, neurocognitive assessment, and structural neuroimaging, does not lead to better prediction.

RSV infection tied to high admissions, deaths in younger children

In children aged <5 years, respiratory syncytial virus infection contributes to high hospital admission and in-hospital mortality rates, reports a Mexico study.

Kids with medical complexity have poor oral health

A study presented at PAS 2024 shows that children with medical complexity (CMC) have poor oral health compared with children with special health care needs (CSHCN).

No developmental boost with low-dose iron in breastfed infants at low anaemia risk

In a setting of low anaemia risk, daily low-dose iron supplements do not appear to have any effect on psychomotor development in breastfed infants between 4 and 9 months, as shown in a study.